Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Oncotarget|September 27, 2017
The Hedgehog-GLI pathway in embryonic development and cancer: implications for pulmonary oncology therapyLeonel Armas-López, Joaquín Zúñiga, Oscar Arrieta, et al.
Salud Publica De Mexico|July 6, 2019
Epigenetics in non-small cell lung carcinomasIrlanda Peralta-Arrieta, Leonel Armas-López, Joaquín Zúñiga, et al.
Clinical Epigenetics|September 15, 2017
Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy responseAbril Marcela Herrera-Solorio, Leonel Armas-López, Oscar Arrieta, et al.
Inflammation|May 3, 2024
Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory CellsRubén D Arroyo-Olarte, Juan C Flores-Castelán, Leonel Armas-López, et al.
Cancer Gene Therapy|February 19, 2025
SMARCB1-driven EGFR-GLI1 epigenetic alterations in lung cancer progression and therapy are differentially modulated by MEOX2 and GLI-1Octavio A Trejo-Villegas, Priscila Pineda-Villegas, Leonel Armas-López, et al.
Oncotarget|October 6, 2017
Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patientsLeonel Armas-López, Patricia Piña-Sánchez, Oscar Arrieta, et al.
European Journal of Immunology|February 14, 2023
STAT6 controls the stability and suppressive function of regulatory T cellsRubén D Arroyo-Olarte, Ana Rivera-Rugeles, Eduardo Nava-Lira, et al.
Molecular Oncology|January 12, 2021
LncRNA SOX2-OT regulates AKT/ERK and SOX2/GLI-1 expression, hinders therapy, and worsens clinical prognosis in malignant lung diseasesAbril Marcela Herrera-Solorio, Irlanda Peralta-Arrieta, Leonel Armas López, et al.
Molecular and Cellular Biology|November 28, 2023
A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent PathwayOlga Villamar-Cruz, Marco Antonio Loza-Mejía, Alonso Vivar-Sierra, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2021
Failure to EGFR-TKI-based therapy and tumoural progression are promoted by MEOX2/GLI1-mediated epigenetic regulation of EGFR in the human lung cancerIrlanda Peralta-Arrieta, Octavio A Trejo-Villegas, Leonel Armas-López, et al.
Pageof 2